Kerr Douglas
Head Of R&d And CMO
Award
Calculated transaction value
$0
8,000 shares @ $0
Traded
Oct 20, 2026
Filed
Oct 22, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Dyne Therapeutics
DYN
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
64 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Kerr Douglas Head Of R&d And CMO | Oct 22, 2026 2-day lag | Award Oct 20, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kerr Douglas Head Of R&d And CMO | Oct 22, 2026 2-day lag | Award Oct 20, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Posner Brian S Director | Oct 6, 2026 4-day lag | Buy Oct 2, 2026 | $40K Filed shares x price | SEC Form 4 View filing | |
| Friedl-naderer Johanna Chief Commercial Officer | Sep 8, 2026 Same-day filing | Sale Sep 8, 2026 | $3.49K Filed shares x price | SEC Form 4 View filing | |
| Friedl-naderer Johanna Chief Commercial Officer | Sep 8, 2026 4-day lag | Sale Sep 4, 2026 | $21.91K Filed shares x price | SEC Form 4 View filing | |
| Kerr Douglas Chief Medical Officer | Sep 8, 2026 Same-day filing | Sale Sep 8, 2026 | $24.36K Filed shares x price | SEC Form 4 View filing | |
| Kerr Douglas Chief Medical Officer | Sep 8, 2026 4-day lag | Sale Sep 4, 2026 | $91.19K Filed shares x price | SEC Form 4 View filing | |
| Cox John CEO & President | Sep 8, 2026 Same-day filing | Sale Sep 8, 2026 | $106.82K Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Aug 17, 2026 3-day lag | Sale Aug 14, 2026 | $8.06M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Aug 17, 2026 3-day lag | Sale Aug 14, 2026 | $33.99M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Aug 17, 2026 3-day lag | Sale Aug 14, 2026 | $11.96M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $1.67M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $7.03M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $2.47M Filed shares x price | SEC Form 4 View filing | |
| Friedl-naderer Johanna Chief Commercial Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $5.94K Filed shares x price | SEC Form 4 View filing | |
| Kerr Douglas Chief Medical Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $40.89K Filed shares x price | SEC Form 4 View filing | |
| Cox John CEO & President | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $131.03K Filed shares x price | SEC Form 4 View filing | |
| Lucera Erick Chief Financial Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $47.23K Filed shares x price | SEC Form 4 View filing | |
| Kersten Dirk Director | Jul 29, 2026 2-day lag | Sale Jul 27, 2026 | $140.32K Filed shares x price | SEC Form 4 View filing | |
| Kersten Dirk Director | Jul 29, 2026 2-day lag | Sale Jul 27, 2026 | $6.53M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 1-day lag | Sale Jul 7, 2026 | $2.88M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 1-day lag | Sale Jul 7, 2026 | $1.14M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 1-day lag | Sale Jul 7, 2026 | $698.84K Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 1-day lag | Sale Jul 7, 2026 | $350.62K Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 1-day lag | Sale Jul 7, 2026 | $275.53K Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 1-day lag | Sale Jul 7, 2026 | $118.05K Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 1-day lag | Sale Jul 7, 2026 | $1.45M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 2-day lag | Sale Jul 6, 2026 | $2.9M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 2-day lag | Sale Jul 6, 2026 | $2.28M Filed shares x price | SEC Form 4 View filing | |
| Rhodes Jason P Director | Jul 8, 2026 2-day lag | Sale Jul 6, 2026 | $5.77M Filed shares x price | SEC Form 4 View filing |
Kerr Douglas
Head Of R&d And CMO
Award
Calculated transaction value
$0
12,000 shares @ $0
Traded
Oct 20, 2026
Filed
Oct 22, 2026
Posner Brian S
Director
Buy
Calculated transaction value
$40K
2,500 shares @ $16
Traded
Oct 2, 2026
Filed
Oct 6, 2026
Friedl-naderer Johanna
Chief Commercial Officer
Sale
Calculated transaction value
$3.49K
185 shares @ $18.88
Traded
Sep 8, 2026
Filed
Sep 8, 2026
Friedl-naderer Johanna
Chief Commercial Officer
Sale
Calculated transaction value
$21.91K
900 shares @ $24.35
Traded
Sep 4, 2026
Filed
Sep 8, 2026
Kerr Douglas
Chief Medical Officer
Sale
Calculated transaction value
$24.36K
1,290 shares @ $18.88
Traded
Sep 8, 2026
Filed
Sep 8, 2026
Kerr Douglas
Chief Medical Officer
Sale
Calculated transaction value
$91.19K
3,745 shares @ $24.35
Traded
Sep 4, 2026
Filed
Sep 8, 2026
Cox John
CEO & President
Sale
Calculated transaction value
$106.82K
5,658 shares @ $18.88
Traded
Sep 8, 2026
Filed
Sep 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$8.06M
322,465 shares @ $25
Traded
Aug 14, 2026
Filed
Aug 17, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$33.99M
1,359,674 shares @ $25
Traded
Aug 14, 2026
Filed
Aug 17, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$11.96M
478,377 shares @ $25
Traded
Aug 14, 2026
Filed
Aug 17, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$1.67M
63,643 shares @ $26.2
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$7.03M
268,354 shares @ $26.2
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$2.47M
94,415 shares @ $26.2
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Friedl-naderer Johanna
Chief Commercial Officer
Sale
Calculated transaction value
$5.94K
226 shares @ $26.28
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Kerr Douglas
Chief Medical Officer
Sale
Calculated transaction value
$40.89K
1,556 shares @ $26.28
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Cox John
CEO & President
Sale
Calculated transaction value
$131.03K
4,986 shares @ $26.28
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Lucera Erick
Chief Financial Officer
Sale
Calculated transaction value
$47.23K
1,797 shares @ $26.28
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Kersten Dirk
Director
Sale
Calculated transaction value
$140.32K
5,388 shares @ $26.04
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Kersten Dirk
Director
Sale
Calculated transaction value
$6.53M
256,072 shares @ $25.5
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$2.88M
124,379 shares @ $23.17
Traded
Jul 7, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$1.14M
49,193 shares @ $23.17
Traded
Jul 7, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$698.84K
29,587 shares @ $23.62
Traded
Jul 7, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$350.62K
14,844 shares @ $23.62
Traded
Jul 7, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$275.53K
11,665 shares @ $23.62
Traded
Jul 7, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$118.05K
5,000 shares @ $23.61
Traded
Jul 7, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$1.45M
62,543 shares @ $23.17
Traded
Jul 7, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$2.9M
127,182 shares @ $22.79
Traded
Jul 6, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$2.28M
100,019 shares @ $22.79
Traded
Jul 6, 2026
Filed
Jul 8, 2026
Rhodes Jason P
Director
Sale
Calculated transaction value
$5.77M
253,039 shares @ $22.79
Traded
Jul 6, 2026
Filed
Jul 8, 2026